newsfilter
← Latest News
ACCESS Newswire·

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

Chief Business Officer, Dylan Wenke, Participates in Virtual Investor "What This Means" SegmentAccess the segment here HOUSTON, TX / ACCESS Newswire / September 1, 2026 / CNS Pharmaceuticals, Inc.